Spero Therapeutics Inc (SPRO.OQ)
SPRO.OQ on NASDAQ Stock Exchange Global Select Market
Change (% chg)
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)
No Ratios Available.